TA Associates looks to acquire stake in Synokem Pharma

Premium

Private equity firm TA Associates has emerged as the frontrunner to acquire a controlling stake in drugmaker Synokem Pharmaceuticals, two people aware of the development said. The US private equity fund is likely to invest around $100 million in Delhi-based Synokem, a contract manufacturer of pharmaceutical formulations such as tablets, capsules, ......